Adenocarcinoma, Papillary: Clinical Trials

186 trials for Adenocarcinoma, Papillary, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

81 completed, 31 unknown, 25 recruiting, 17 active not recruiting. 53 Phase 2, 44 Not applicable, 23 Phase 1, 8 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 253Completed 26, Active not recruiting 11, Terminated 7, Recruiting 5, Unknown 3, Not yet recruiting 1
Not applicable44Completed 17, Unknown 10, Not yet recruiting 6, Recruiting 5, Terminated 5, Active not recruiting 1
Phase 123Completed 16, Active not recruiting 3, Terminated 2, Unknown 1, Withdrawn 1
Phase 38Recruiting 3, Active not recruiting 2, Completed 2, Unknown 1
Phase 42Not yet recruiting 1, Unknown 1
Early Phase 11Unknown 1

Follow Adenocarcinoma, Papillary: new trials by email Literature Review of Adenocarcinoma, Papillary trials Research Report on Adenocarcinoma, Papillary

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial
Internet-Based Intervention, Interview, Questionnaire Administration - Differentiated Thyroid Gland Carcinoma, Malignant Testicular Neoplasm
Not applicableNot yet recruitingUniversity of Michigan Rogel Cancer Center1422026-12-012026-10-15
Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)
Sacituzumab Tirumotecan - Recurrent Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma Metastatic
Phase 2Not yet recruitingNational Cancer Centre, Singapore682026-11-012026-07-15
Bethesda Classification and Risk Stratification in Differentiated Thyroid Carcinoma
Differentiated Thyroid Carcinoma, Papillary Thyroid Carcinoma
Not yet recruitingAssiut University1002026-10-262026-10-05
Pattern and Surgical Outcome of Papillary Thyroid Cancer at Sohag University Hospitals
Papillary Thyroid Carcinoma, Thyroid Cancer
Not yet recruitingSohag University302026-09-162026-09-16
Health and Wellness Coaching to Improve Adherence to Healthy Habits and Treatment Plans in Papillary and Follicular Thyroid Cancer Survivors
Counseling, Interview, Questionnaire Administration - Thyroid Gland Follicular Carcinoma, Thyroid Gland Papillary Carcinoma
Not applicableRecruitingMayo Clinic202026-06-232026-07-08
Decision Aid Efficacy in Low Risk Thyroid Cancer
Decision Aid - Differentiated Thyroid Cancer (DTC), Papillary Thyroid Microcarcinoma
Not applicableNot yet recruitingUniversity of Maryland, Baltimore342026-05-152026-04-17
The Role of Prophylactic Central Compartment Neck Dissection in the Management of 2 to 4 cm Papillary Thyroid Carcinoma
Total Thyroidectomy + Central Compartment Neck Dissection, Thyroid Lobectomy + ipCCND - Papillary Thyroid Carcinoma, Central Compartment Neck Dissction
Not applicableNot yet recruitingLeonardo Rossi3922026-04-282026-05-05
DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
Dabrafenib, Trametinib - Haematological Malignancy, Malignant Neoplasm
Phase 2 / Phase 3RecruitingCancer Research UK302026-04-012026-08-17
Clinical Utility of Preoperative Thyroid GuidePx® Testing
Papillary Thyroid Cancer, Papillary Thyroid Carcinoma
Not yet recruitingUniversity of Calgary852026-04-012026-06-01
Radiofrequency Ablation for Curative Treatment of Small Low-Risk Papillary Thyroid Cancer: Pilot Study
Radiofrequency Ablation of Papillary Thyroid Cancer, VIVA combo RF Generator with Coagulation Electrode - Thyroid Papillary Carcinoma
Not applicableRecruitingUniversity Health Network, Toronto302026-02-052026-05-19
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
mitoxantrone hydrochloride injection - Papillary Thyroid Cancer
Phase 4Not yet recruitingDaping Hospital and the Research Institute of Surgery of the Third Military Medical University1142026-02-012026-01-21
Multimodal Deep Learning for Lymph Node Metastasis in Thyroid Cancer
not intervention - Papillary Thyroid Carcinoma
Not yet recruitingWest China Hospital32002026-01-012025-12-23
Humanistic Continuing Care Via WeChat for Patients Undergoing Thermal Ablation of Papillary Thyroid Carcinoma
Humanistic Continuing Care via WeChat, Usual Care (No Structured WeChat Program) - Papillary Thyroid Carcinoma
Not applicableRecruitingMing-an Yu1082025-12-152026-07-14
Preoperative Prediction of Lymph Node Metastasis in T1N0M0 Papillary Thyroid Carcinoma by Using Contrast-enhanced Ultrasound
Thyroid Papillary Carcinoma, Contrast Enhanced Ultrasound
RecruitingSun Yat-Sen Memorial Hospital of Sun Yat-Sen University6002025-12-012026-01-22
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Questionnaire - Low Risk, Papillary Thyroid Cancer
RecruitingM.D. Anderson Cancer Center502025-08-182026-09-16
RET-US Study - Ultrasound-Based Prediction of RET Alterations and Lateral-Neck Metastasis in Thyroid Cancer
AI-Ultrasound RET Prediction - Papillary Thyroid Carcinoma, Thyroid Neoplasms
Not yet recruitingFujian Medical University8002025-07-012025-06-29
XL092 for the Treatment of Locally Advanced or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer
Biospecimen Collection, Computed Tomography, Magnetic Resonance Imaging - Locally Advanced Differentiated Thyroid Gland Carcinoma, Locally Advanced Poorly Differentiated Thyroid Gland Carcinoma
Phase 2RecruitingJochen Lorch332025-06-062026-06-26
Necessity of TSH Suppression Therapy in Active Surveillance for Thyroid Cancer Patients.
Levothyroxin - Thyroid Cancer, Papillary Thyroid Carcinoma
Not applicableNot yet recruitingNational Cancer Center, Korea5782025-06-022025-05-14
Analysis of Long-term Outcomes of Endoscopic Resection of Duodenal and Ampullary Mucosal and Submucosal Lesions
Duodenal Adenoma, Duodenal Carcinoma
RecruitingWestern Sydney Local Health District10002025-05-232026-08-24
Shared Decision-Making for Determining Treatment Strategies in Low-Risk Thyroid Cancer
SDM protocol - Thyroid Cancer, Papillary Thyroid Carcinoma
Not applicableNot yet recruitingNational Cancer Center, Korea3102025-05-122025-04-30

Showing 20 of 186. Sign in to see all of them.

Narrower conditions

Thyroid Cancer, Papillary (183)  ·  Thyroid Neoplasms (81)  ·  Adenocarcinoma, Follicular (59)  ·  Carcinoma, Medullary (27)  ·  Head and Neck Neoplasms (22)  ·  Carcinoma, Non-Small-Cell Lung (18)  ·  Thyroid Carcinoma, Anaplastic (18)  ·  Lymphatic Metastasis (13)  ·  Colonic Neoplasms (12)  ·  Colorectal Neoplasms (12)  ·  Salivary Gland Neoplasms (12)  ·  Breast Neoplasms (11)  ·  Neoplasms (11)  ·  Melanoma (10)  ·  Pancreatic Neoplasms (10)

Broader conditions

Adenocarcinoma (185)  ·  Carcinoma (185)  ·  Neoplasms, Glandular and Epithelial (185)  ·  Neoplasms by Histologic Type (183)  ·  Endocrine Gland Neoplasms (180)  ·  Endocrine System Diseases (180)  ·  Neoplasms by Site (179)  ·  Neoplasms (175)  ·  Thyroid Diseases (175)  ·  Head and Neck Neoplasms (161)  ·  Thyroid Neoplasms (102)  ·  Neoplasms, Germ Cell and Embryonal (40)  ·  Neoplasms, Nerve Tissue (40)  ·  Neuroectodermal Tumors (40)

Interventions

Magnetic Resonance Spectroscopy (10)  ·  Iodine-131 (8)  ·  Thyrotropin Alfa (5)  ·  selpercatinib (5)  ·  Specimen Handling (4)  ·  Thyroidectomy (4)  ·  Vemurafenib (4)  ·  dabrafenib (4)  ·  trametinib (4)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (3)  ·  Fluorodeoxyglucose F18 (3)  ·  Nivolumab (3)  ·  Radiofrequency Ablation (3)  ·  Sorafenib (3)  ·  Sunitinib (3)

Sponsors

National Cancer Institute (NCI) (19)  ·  Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (6)  ·  Chinese PLA General Hospital (4)  ·  Fujian Medical University (4)  ·  Hoffmann-La Roche (4)  ·  M.D. Anderson Cancer Center (4)  ·  Massachusetts General Hospital (4)  ·  University Health Network, Toronto (4)  ·  Eli Lilly and Company (3)  ·  Exelixis (3)  ·  Mayo Clinic (3)  ·  Memorial Sloan Kettering Cancer Center (3)  ·  National Cancer Center, Korea (3)  ·  Radboud University Medical Center (3)  ·  Second Affiliated Hospital of Xi'an Jiaotong University (3)

Countries

United States (76)  ·  China (40)  ·  Italy (16)  ·  South Korea (16)  ·  Canada (15)  ·  France (11)  ·  Spain (11)  ·  Australia (10)  ·  Germany (10)  ·  United Kingdom (10)  ·  Netherlands (9)  ·  Hong Kong (6)  ·  Taiwan (6)  ·  Israel (5)  ·  Japan (5)

Top investigators

Manisha Shah (3)  ·  Alan L Ho (2)  ·  Alan L Ho, MD, PhD (2)  ·  David Pfister (2)  ·  Dian Ouyang (2)  ·  Electron Kebebew, MD (2)  ·  Eun Kyung Lee (2)  ·  Kenneth Ain, MD (2)  ·  Steven Sherman (2)  ·  Young Joo Park (2)  ·  Yukun Luo (2)  ·  Abd Moain Abu Dabrh, MB, BCh, MS (1)

Results publications

PMID 31838007, PMID 36657661, PMID 37934000, PMID 40086048, PMID 16522694, PMID 17985341, PMID 17985985, PMID 18596272, PMID 18854394, PMID 19372041, PMID 19602035, PMID 19735988, PMID 19773250, PMID 19850694, PMID 20145168, PMID 20739388, PMID 21034228, PMID 21367608, PMID 21750043, PMID 22136820, PMID 22167004, PMID 22313454, PMID 22551128, PMID 22827494, PMID 22967508, PMID 23188784, PMID 23868427, PMID 24050953, PMID 24827131, PMID 25549723, PMID 25590215, PMID 25692116, PMID 25928353, PMID 26046782, PMID 26135963, PMID 26462967, PMID 26671977, PMID 27083216, PMID 27169792, PMID 27467318, PMID 28252836, PMID 28258306, PMID 28513893, PMID 28662033, PMID 28699990, PMID 28817373, PMID 28915656, PMID 29020892, PMID 29118225, PMID 29128185

NIH funding

N01CM62207 (4), 2023 (3), N01CM62201 (3), N01CM62206 (3), P30CA015083 (3), N01CM00071 (2), N01CM00099 (2), N01CM62202 (2), N01CM62203 (2), P30CA008748 (2), P30CA014599 (2), P30CA016058 (2), U01CA076576 (2), 2005 (1), 2015 (1)